as of 2018 - 05 - 18

C.8.6.1 Questions and answers on implementation of risk-based prevention of cross-contamination in production and ‘Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities’ (EMA/CHMP/CVMP/SWP/169430/2012)

C.8.6.1 Questions and answers on implementation of risk-based prevention of cross-contamination in production and
‘Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities’
(EMA/CHMP/CVMP/SWP/169430/2012)
Up4/2018

A paid subscription is needed to login into the GMP Compliance Adviser. Click here for more information.

Username
Password
enlarge font size by using the short cut 'ctrl' and '+' (from IE 7, Firefox)